
Revamaf-D 80mg/250mg Tablet
Marketer
Future Dermacare Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Revamaf-D 80mg/250mg Tablet
Combiflam-D 80mg/250mg tablets offer relief from abdominal pain. This dual-action medication alleviates bloating, cramps, and discomfort by relaxing the stomach and intestinal muscles, and inhibiting pain-inducing chemical signals. Always take Combiflam-D 80mg/250mg tablets with food, following your doctor's prescribed dosage and duration. Treatment length depends on your individual response and condition; premature discontinuation may lead to symptom recurrence and worsening. Inform your physician of all other medications you are using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, appetite loss, thirst, and heartburn; most are transient. Report any concerning side effects immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring concentration until effects are known. Alcohol consumption should be avoided due to potential increased dizziness. Consult your doctor before use if pregnant, planning pregnancy, breastfeeding, or if you have kidney or liver conditions, to ensure appropriate dosage.
Primary Ingredients of Revamaf-D 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Revamaf-D 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Revamaf-D 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Revamaf-D 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Revamaf-D 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Revamaf-D 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Revamaf-D 80mg/250mg Tablet should be administered with a meal.
How Revamaf-D 80mg/250mg Tablet works:
Each Revamaf-D 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-inducing substances in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Revamaf-D 80mg/250mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Revamaf-D 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Revamaf-D 80mg/250mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Revamaf-D 80mg/250mg Tablets, a potential side effect of this medication, namely vertigo.
KidneyCAUTION
Patients with kidney impairment should use Revamaf-D 80mg/250mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Revamaf-D 80mg/250mg tablets are contraindicated in those with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Revamaf-D 80mg/250mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Revamaf-D 80mg/250mg Tablet :
Should you forget a Revamaf-D 80mg/250mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Revamaf-D 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |
